RCMC
LGND icon

RK Capital Management (Colorado)’s Ligand Pharmaceuticals LGND Stock Holding History

RK Capital Management (Colorado)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-151,617
Closed -$12.8M – 54
2018
Q4 		$12.8M Buy
151,617
+103,234
+213% +$11M 3.65% 9
2018
Q3 		$8.29M Sell
48,383
-33,503
-41% -$5.05M 1.87% 25
2018
Q2 		$10.6M Buy
81,886
+4,649
+6% +$519K 2.33% 16
2018
Q1 		$7.96M Buy
77,237
+15,068
+24% +$1.49M 1.73% 30
2017
Q4 		$5.31M Sell
62,169
-73,578
-54% -$6.38M 1.12% 46
2017
Q3 		$11.5M Sell
135,747
-145,873
-52% -$11.6M 2.69% 11
2017
Q2 		$21.3M Sell
281,620
-7,694
-3% -$538K 4.29% 1
2017
Q1 		$19.1M Sell
289,314
-18,274
-6% -$1.2M 3.69% 3
2016
Q4 		$19.5M Buy
307,588
+16,831
+6% +$1.06M 4.04% 5
2016
Q3 		$18.5M Buy
290,757
+93,615
+47% +$6.87M 3.59% 3
2016
Q2 		$14.7M Sell
197,142
-46,166
-19% -$3.43M 2.62% 13
2016
Q1 		$16.3M Buy
243,308
+38,151
+19% +$2.32M 2.69% 14
2015
Q4 		$13.9M Buy
205,157
+66,204
+48% +$4.09M 2.42% 18
2015
Q3 		$7.42M Buy
138,953
+85,280
+159% +$5.17M 1.36% 34
2015
Q2 		$3.38M Sell
53,673
-60,594
-53% -$3.31M 0.61% 51
2015
Q1 		$5.5M Sell
114,267
-210,474
-65% -$8.06M 1.1% 41
2014
Q4 		$10.8M Buy
324,741
+45,365
+16% +$1.48M 2.13% 23
2014
Q3 		$8.19M Buy
279,376
+80,069
+40% +$2.66M 1.67% 31
2014
Q2 		$7.75M Buy
199,307
+44,082
+28% +$1.79M 1.54% 35
2014
Q1 		$6.51M Sell
155,225
-61,715
-28% -$2.57M 1.32% 38
2013
Q4 		$7.12M Buy
216,940
+57,212
+36% +$1.86M 1.75% 31
2013
Q3 		$4.31M Buy
+159,728
New +$4.49M 1.23% 41

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

RK Capital Management (Colorado)'s LGND Position: Q1 2019 in Review

RK Capital Management (Colorado) sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 151,617 shares — an estimated $12.8M sold.

RK Capital Management (Colorado) first reported a position in LGND in Q3 2013 and held it in 22 quarters. The position peaked at $21.3M in Q2 2017. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • RK Capital Management (Colorado) reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • RK Capital Management (Colorado) sold 151,617 Ligand Pharmaceuticals shares in Q1 2019, an estimated $12.8M.
  • RK Capital Management (Colorado) first reported a position in Ligand Pharmaceuticals in Q3 2013 and held it in 22 quarters.
  • RK Capital Management (Colorado)'s Ligand Pharmaceuticals position peaked at $21.3M in Q2 2017.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on RK Capital Management (Colorado)'s 13F filing for Q1 2019, filed 14 May 2019.